These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 19127138)

  • 81. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J; Louis E; Persy V; Urbain D
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Gastric acidity inhibitors and the risk of intestinal infections.
    Canani RB; Terrin G
    Curr Opin Gastroenterol; 2010 Jan; 26(1):31-5. PubMed ID: 19907324
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Achievements in esophagology during 2008.
    Tytgat GN
    Curr Opin Gastroenterol; 2009 Jul; 25(4):339-41. PubMed ID: 19448532
    [No Abstract]   [Full Text] [Related]  

  • 89. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
    MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
    [No Abstract]   [Full Text] [Related]  

  • 90. Potential adverse effects of proton pump inhibitors.
    Coté GA; Howden CW
    Curr Gastroenterol Rep; 2008 Jun; 10(3):208-14. PubMed ID: 18625128
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment patterns and symptom control in patients with GERD: US community-based survey.
    Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
    Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.
    Metz DC; Vakily M; Dixit T; Mulford D
    Aliment Pharmacol Ther; 2009 May; 29(9):928-37. PubMed ID: 19298580
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Focus on multi-morbidity patients. Considering the greatest measure of therapy safety].
    MMW Fortschr Med; 2007 Dec; 149(49-50):59. PubMed ID: 18236986
    [No Abstract]   [Full Text] [Related]  

  • 95. Persistent heartburn in a patient on proton-pump inhibitor.
    Fass R
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):393-400. PubMed ID: 18387497
    [No Abstract]   [Full Text] [Related]  

  • 96. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prescribing proton pump inhibitors: is it time to pause and rethink?
    Vakil N
    Drugs; 2012 Mar; 72(4):437-45. PubMed ID: 22356286
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 100. Are proton pump inhibitors really so dangerous?
    Savarino V; Dulbecco P; Savarino E
    Dig Liver Dis; 2016 Aug; 48(8):851-9. PubMed ID: 27321544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.